Medicine, Health
Challenging Darwin: an ‘evolution machine’ for biomolecules
Challenging Darwin: an ‘evolution machine’ for biomolecules Darwin would be puzzled. He described natural selection as a slow process, selecting for the most suited organisms to a given environment.
Do microbes control our mood?
Do microbes control our mood? If aliens were to examine a human, they would think we were just slavish organisms designed to feed microbes and carry them around. Our bodies contain ten times more bacteria than cells , and there are an estimated 3.
Twins help progress and diagnosis of rare Myasthenia
Twins help progress and diagnosis of rare Myasthenia Fourteen pairs of identical twins joined the EU funded medical project “ Fight-MG ”, to fight Myasthenia Gravis . This rare autoimmune disease leads to abnormal fatigability of various skeletal muscles.
Sonia Aknin-Berrih: How rare models suggest new treatment strategies
Sonia Aknin-Berrih: How rare models suggest new treatment strategies Myasthenia Gravis (MG) is a rare auto-immune disease—whereby patients’ immune systems attack their own bodies— arising from a breakdown in communications between the nervous and muscular systems.
Network of experts join forces to fight rare disease
Network of experts join forces to fight rare disease Collaboration between research groups is key in tackling rare diseases such as auto-immune disease Myasthenia Gravis (MG). Indeed, the rarity of the disease means that it can be difficult to collect enough samples of blood and tissues to perform quality research.
Designing ultra-sensitive biosensors for early personalised diagnostics
Designing ultra-sensitive biosensors for early personalised diagnostics Personalised medicine is one of the new developments that is deemed to revolutionise health care. A key component is the detection of biomarkers, proteins in blood or saliva, for example, whose presence or abnormal concentration is caused by a disease.
Pietro Gucciardi – Working towards a single-molecule biosensor
Pietro Gucciardi – Working towards a single-molecule biosensor Until now, few biosensors have had the required sensitivity to detect single molecules. A novel approach for improved biosensor sensitivity has opened new avenues for developing new kinds of biosensors.
Gene correction for a rare disease
Gene correction for a rare disease Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood.
Renewed hope for gene therapy in rare disease
Renewed hope for gene therapy in rare disease Between 30 and 40 million people in Europe suffer from rare diseases —many of them children. As most of these diseases have genetic origins, gene therapy is a major hope for their future cure .
Gloria González-Aseguinolaza - Positive signs for curative treatment against Porphyria
Gloria González-Aseguinolaza - Positive signs for curative treatment against Porphyria Patients with Acute Intermittent Porphyria (AIP) are permanently tired. They continuously suffer acute pain, severe motor affection and an array of neurological problems. AIP affects one in 10,000 people in the EU.
Forecasting pollen in the atmosphere
Forecasting pollen in the atmosphere Runny nose, watery eyes and cough; these are the symptoms associated with respiratory allergies. About 20% to 30% of Europeans suffer from some type of respiratory allergy , according to the European Federation of Allergy and Airway Diseases Patients Associations .
Secrets of youth, based on prevention
Secrets of youth, based on prevention We age in two ways. There is the ageing we count by clock and calendar. And then there is biological ageing. The latter is written into our genes. But, it is also influenced by our lifestyle and history.
Ana Valdes – Twins studies to identify the molecular cause of ageing
Ana Valdes – Twins studies to identify the molecular cause of ageing What makes us age biologically? We have always been intrigued by this question. Yet, it remains a fundamental research challenge.  Now, the EU-funded project, EurHEALTHAgeing , aims to draw together studies of early development with those on longevity and ageing.
Picking the right virus candidate for gene therapy
Picking the right virus candidate for gene therapy Viruses often get bad press. Likened to Trojan horses they are often associated with disease. But, i t is precisely because of their infectious nature that they can potentially be used as gene vectors - which are vehicles loaded with good copies of malfunctioning genes - and delivered to cells.
Eric Kremer – Delivering therapy beyond the blood-brain barrier
Eric Kremer – Delivering therapy beyond the blood-brain barrier Brain diseases are particularly challenging to treat. Every substance that has to be delivered to the brain needs to overcome several obstacles, such as the blood-brain barrier—a system that prevents potentially dangerous substances, but also many drugs, to enter this organ—,to get to its target.
Human Bones from the Lab
Human Bones from the Lab Scientists in Würzburg, in Germany, have created living bone material from human stem cells in their laboratory. The discipline is called tissue engineering and the aim of the scientists is to produce the perfect substitute for bone transplantation.
Healing bone defects using regenerative medicine
Healing bone defects using regenerative medicine Bone is one of the most frequently transplanted tissues. And the demand is rising. Transplants treat large defects like those caused by trauma, complicated fractures, tumour resection or osteoporosis. ...
Page: 1 2 3 4 5 6 7